Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydroxyquinolone is a **small-molecule vaginal anti-infective** used in topical gynecologic care and marketed as **Trimo-San** vaginal gel. It is formulated as an acidifying vaginal gel, commonly at **0.025%**, and is used to help maintain an acidic vaginal pH, reduce bacterial overgrowth, control odor, and provide lubrication, particularly in women using a vaginal pessary for pelvic organ support. Its effect is local rather than systemic, with antimicrobial activity attributed to inhibition of bacterial growth within the vaginal environment rather than a defined single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydroxyquinolone.